Sartorius AG

euro adhoc: Sartorius AG
Financial Figures/Balance Sheet
Ad hoc Announcement According to Section 15 of the German Securities Trading Act (WpHG) Figures for the First Nine Months of 2005 Group sales revenue up 4.7%; currency-adjusted figure up 5.6%

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc.   The issuer is responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@


In the first nine months of fiscal 2005, Group sales revenue rose 4.7% (currency adjusted: +5.6%) to EUR353.5 million (previous year: EUR337.5 mn). Sales revenue for the Biotechnology Division climbed 8.3% (currency-adjusted: +9.2%) to EUR185.0 million (EUR170.8 mn). In the Mechatronics Division, sales revenue increased 1.1% (currency-adjusted: +1.8%), attaining EUR168.5 million (EUR166.6 mn). At EUR365.3 million, order intake at the Group level was up 5.1% (currency adjusted: +5.8%) from the year-earlier figure (EUR347.6 mn). EBITDA grew 8.2% to EUR39.6 million (EUR36.6 mn); EBIT surged 25.6% to EUR25.5 million (EUR20.3 mn). For the Biotechnology Division, EBIT jumped significantly from EUR10.2 million to EUR15.2 million, whereas EBIT for the Mechatronics Division at EUR10.3 million was slightly above the previous year’s level (EUR10.1 mn). The Group EBIT margin improved from 6.0% to 7.2%. Earnings per share climbed from EUR0.55 to EUR0.79. Nine-month net cash flow attained EUR13.7 million (EUR21.8 mn). Our gross debt dropped EUR4.4 million relative to December 31, 2004, and as of September 30, 2005, is at EUR81.2 million (net debt: EUR73.6 mn). On the basis of the nine-month figures for 2005, we continue to adhere to our growth and earnings targets for the current financial year. We expect a further increase in earnings to an EBIT of over eight percent of consolidated sales revenue and full-year growth below the rate of the first nine months.

@@start.t2@@end of announcement                                                 euro adhoc 19.10.2005 20:19:08

ots Originaltext: Sartorius AG
Im Internet recherchierbar:

Further inquiry note:
Andreas Wiederhold
Phone: +49.551.308.1668

Branche: Biotechnology
ISIN:      DE0007165607
WKN:        716560
Index:    Prime Standard, CDAX, Prime All Share, Technologie All Share
Börsen:  Berliner Wertpapierbörse / free trade
              Hamburger Wertpapierbörse / free trade
              Baden-Württembergische Wertpapierbörse / free trade
              Börse Düsseldorf / free trade
              Bayerische Börse / free trade
              Bremer Wertpapierbörse (BWB) / free trade
              Frankfurter Wertpapierbörse / official dealing
              Niedersächsische Börse zu Hannover / official dealing

Weitere Meldungen: Sartorius AG

Das könnte Sie auch interessieren: